Hydroxychloroquine - An Antimalarial and Anti-inflammatory Drug
Main Article Content
Abstract
Hydroxychloroquine – a quinoline antimalarial, has hypoglycemic effects that manifest due to its action on the intracellular insulin metabolism in peripheral tissues. Recent studies confirm that the use of Hydroxychloroquine can aid in preventing new onset diabetes and complications of diabetes, systemic lupus erythematosus and rheumatoid arthritis, as well as in improving the mortality rate of these patients.
Article Details
Issue
Section
Review Article

This work is licensed under a Creative Commons Attribution 4.0 International License.